Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry

Comprehensive genomic profiling (CGP) and immunohistochemistry (IHC) are important biomarker tools used for patients with non-small cell lung cancer (NSCLC) given the expanding number of standard-of-care therapies that require companion diagnostic testing. We examined 9450 NSCLC real-world patient s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pathol Oncol Res
Autori principali: Huang, Richard S. P., Severson, Eric, Haberberger, James, Duncan, Daniel L., Hemmerich, Amanda, Edgerly, Claire, Ferguson, N. Lynn, Frampton, Garrett, Owens, Clarence, Williams, Erik, Elvin, Julia, Vergilio, Jo-Anne, Killian, Jonathan Keith, Lin, Douglas, Morley, Samantha, McEwan, Deborah, Holmes, Oliver, Danziger, Natalie, Cohen, Michael B., Sathyan, Pratheesh, McGregor, Kimberly, Reddy, Prasanth, Venstrom, Jeffrey, Anhorn, Rachel, Alexander, Brian, Brown, Charlotte, Ross, Jeffrey S., Ramkissoon, Shakti H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Society Journal Archive
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8262230/
https://ncbi.nlm.nih.gov/pubmed/34257540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.592997
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi